Respiratory syncytial virus infection research hub
4 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of MK-3508 in Healthy Participants
This study is testing a new medicine, MK-3508, for a common cold-like illness called RSV. Researchers want to see if it's safe, how well people tolerate it, and how the body handles the medicine. It's for healthy adult men.
Belgium - ongoing, recruitingHuman Pharmacology (Phase I)- Other
MK-3508 Multiple Ascending Dose Study in Healthy Participants
This study is looking into a new medicine called MK-3508. It's designed to help fight a common cold-like illness called RSV. We want to see how safe the medicine is at different doses and how the body handles it in healthy adult volunteers.
Belgium - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A clinical study of MK-3508 in healthy people (MK-3508-006)
This study is looking into a new medicine, MK-3508, for healthy people. It's designed to see how the medicine works in the body and if it's safe. The goal is to help protect against a common chest infection called RSV.
Belgium - authorisedHuman Pharmacology (Phase I)- Other
Treatment of Respiratory Complications Associated with COVID-19, Influenza A, Metapneumovirus, Respiratory Syncytial Virus (RSV) Infection Using Wharton’s Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans®): open Phase IB Clinical Trial
This study is testing a new treatment for serious breathing problems caused by viruses like COVID-19 and flu. It uses special cells from umbilical cords to help people aged 18 and over who are very ill get better. It's an early-stage study to see if the treatment is safe.
Sweden